GSK plc
GSK
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The compaā¦ read more
Healthcare
Drug ManufacturersāGeneral
45 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$46.63
Price-1.00%
-$0.47
1Y
Price
Market Cap
$94.810b
Large
Price/Earnings 3y Avg5y Avg
13.4x
Premium
Premium
Financials Overview
Key metrics over the past few years+4.3%
EBITDA Margin+4.2%
Net Profit Margin-
Free Cash Flow MarginRevenue
$297.238b
+847.3%
1y CAGR+284.7%
3y CAGR+218.2%
5y CAGREarnings
$15.087b
+485.9%
1y CAGR+123.7%
3y CAGR+153.0%
5y CAGREPS
$7.32
+490.3%
1y CAGR+147.3%
3y CAGR+107.7%
5y CAGRBook Value
$9.881b
$12.877b
Assets$2.996b
Liabilities$478m
DebtDebt to Assets
3.7%
-
Debt to EBITDAFree Cash Flow
$3.354b
-6.1%
1y CAGR-13.1%
3y CAGR-9.2%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company